Invesco’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.73M | Buy |
467,209
+100,559
| +27% | +$1.45M | ﹤0.01% | 2025 |
|
|
2025
Q1 | $2.53M | Buy |
366,650
+336,422
| +1,113% | +$2.32M | ﹤0.01% | 2441 |
|
|
2024
Q4 | $160K | Sell |
30,228
-6,481
| -18% | -$34.4K | ﹤0.01% | 3535 |
|
|
2024
Q3 | $134K | Sell |
36,709
-53,010
| -59% | -$193K | ﹤0.01% | 3564 |
|
|
2024
Q2 | $245K | Buy |
+89,719
| New | +$245K | ﹤0.01% | 3542 |
|
|
2022
Q2 | – | Sell |
-15,789
| Closed | -$39K | – | 4130 |
|
|
2022
Q1 | $39K | Sell |
15,789
-390
| -2% | -$963 | ﹤0.01% | 3913 |
|
|
2021
Q4 | $61K | Sell |
16,179
-468
| -3% | -$1.77K | ﹤0.01% | 3923 |
|
|
2021
Q3 | $104K | Buy |
16,647
+4,094
| +33% | +$25.6K | ﹤0.01% | 3901 |
|
|
2021
Q2 | $124K | Sell |
12,553
-799,151
| -98% | -$7.89M | ﹤0.01% | 3836 |
|
|
2021
Q1 | $7.58M | Buy |
+811,704
| New | +$7.58M | ﹤0.01% | 2130 |
|
|
2019
Q2 | – | Sell |
-67,207
| Closed | -$282K | – | 3742 |
|
|
2019
Q1 | $282K | Buy |
67,207
+5,630
| +9% | +$23.6K | ﹤0.01% | 3485 |
|
|
2018
Q4 | $211K | Sell |
61,577
-15,892
| -21% | -$54.5K | ﹤0.01% | 3516 |
|
|
2018
Q3 | $332K | Buy |
77,469
+17,871
| +30% | +$76.6K | ﹤0.01% | 3538 |
|
|
2018
Q2 | $221K | Sell |
59,598
-112,504
| -65% | -$417K | ﹤0.01% | 3647 |
|
|
2018
Q1 | $723K | Buy |
+172,102
| New | +$723K | ﹤0.01% | 3183 |
|
|
2017
Q2 | – | Sell |
-22,638
| Closed | -$61K | – | 3728 |
|
|
2017
Q1 | $61K | Buy |
22,638
+2,865
| +14% | +$7.72K | ﹤0.01% | 3677 |
|
|
2016
Q4 | $65K | Buy |
19,773
+526
| +3% | +$1.73K | ﹤0.01% | 3632 |
|
|
2016
Q3 | $57K | Buy |
19,247
+394
| +2% | +$1.17K | ﹤0.01% | 3611 |
|
|
2016
Q2 | $78K | Buy |
+18,853
| New | +$78K | ﹤0.01% | 3637 |
|